The Efficacy And Safety Of VP-16 And G-CSF As A Mobilization Regimen Prior To Autologous Stem Cell Transplantation (ASCT) For Patients (PTS) With Multiple Myeloma (MM) And Lymphoma
Year: 2010
Type: article
Abstract: There remains little consensus about the best means for mobilizing stem cells prior to ASCT. Cytokine alone, usually G-CSF, provides easy scheduling while the combination approaches generally provide higher cell yields and additional cytoreduction. Because of its value as a cytoreductive agent, and its lack of stem cell damaging properties or other toxicities, we investigated the use of mid-dose VP-16 plus G-CSF as a mobilizing regimen.
Institution: University of North Carolina at Chapel Hill
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2040697273